Abstract
Shiga toxins have been shown to induce apoptosis on primary cultures, but not passaged ones, of human umbilical vein endothelial cells, independent of cytokine pre-treatment. Here, a peculiar pattern of caspase activation was observed; caspase-3 and -2, but not conventional upstream caspases, were activated at the initial phase of 6 hr, whereas a broad range inhibitor of caspases, VAD-fmk, but not mono-specific ones, suppressed DNA fragmentation and cell death. These results suggest additional analogous molecules, which have yet to be delineated, are involved. The requirement of retrograde uptake of toxins was also proved by the intervening effect of brefeldin A.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Chloromethyl Ketones / pharmacology
-
Apoptosis / drug effects*
-
Apoptosis / physiology
-
Brefeldin A / pharmacology
-
Caspase 2
-
Caspase 3
-
Caspases / metabolism*
-
Cysteine Proteinase Inhibitors / pharmacology
-
DNA Fragmentation / drug effects
-
Endothelium, Vascular / cytology
-
Endothelium, Vascular / enzymology*
-
Enzyme Activation
-
Flow Cytometry
-
Humans
-
Protein Synthesis Inhibitors / pharmacology
-
Shiga Toxins / pharmacology*
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
Substances
-
Amino Acid Chloromethyl Ketones
-
Cysteine Proteinase Inhibitors
-
Protein Synthesis Inhibitors
-
Shiga Toxins
-
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
-
Brefeldin A
-
CASP3 protein, human
-
Caspase 2
-
Caspase 3
-
Caspases